[144] BeOne Medicines Ltd. SEC Filing

Rhea-AI Filing Summary

ONC filed a Form 144 indicating that stockholder Xiaobin Wu plans to sell 3,991 shares of common stock through Morgan Stanley Smith Barney LLC on or about 11/17/2025, with an aggregate market value of $1,518,302.91. The shares are listed on NASDAQ, and the issuer reports 109,663,273 common shares outstanding.

The seller acquired 1,238 and 2,753 common shares through restricted stock vesting under a registered plan in June 2025. Over the past three months, the seller reported additional sales of 6,009 and 10,000 common shares, with gross proceeds of $2,286,659.45 and $3,560,160.50, respectively.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3991	1518302.91	109663273	11/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2025	Restricted stock vesting under a registered plan	Issuer			1238	06/15/2025	Not Applicable
Common	06/05/2025	Restricted stock vesting under a registered plan	Issuer			2753	06/05/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
XIAOBIN WU 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	Common	11/13/2025	6009	2286659.45
Xiaobin Wu 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	Common	11/12/2025	10000	3560160.50

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ONC's latest Form 144 filing disclose?

The Form 144 filing discloses that Xiaobin Wu intends to sell 3,991 shares of ONC common stock with an aggregate market value of $1,518,302.91 through Morgan Stanley Smith Barney LLC.

How many ONC shares are planned to be sold and when?

The notice states that 3,991 common shares are to be sold, with an approximate sale date of 11/17/2025 on the NASDAQ exchange.

How were the ONC shares in this Form 144 acquired?

The shares were acquired as restricted stock vesting under a registered plan, including 1,238 shares on 06/15/2025 and 2,753 shares on 06/05/2025, both from the issuer.

How many ONC shares has the seller disposed of in the last 3 months?

Over the past three months, the seller reported sales of 6,009 common shares on 11/13/2025 for $2,286,659.45 and 10,000 common shares on 11/12/2025 for $3,560,160.50.

How many ONC common shares are outstanding according to the filing?

The Form 144 indicates that there are 109,663,273 ONC common shares outstanding.

Which broker is handling the planned ONC share sale in the Form 144?

The planned sale of 3,991 ONC common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.